Miniature synchrotron produces first light

In 2004 Lyncean Technologies announced the construction of the Compact Light Source (CLS), a miniature synchrotron to produce high-intensity, tunable, near-monochromatic X-ray beams. The Compact Light Source was specifically designed to bring state-of-the-art protein structure determination to the university or industrial laboratory--but it has also promised a broad impact across the spectrum of x-ray science.

Today, Ronald Ruth, Ph.D., president of Lyncean Technologies, announced that the CLS prototype is up and running and has just produced its first X-ray beams.

It is, perhaps, old news that synchrotron light has revolutionized x-ray research across the physical and biological sciences. Perhaps the most striking examples of its impact come from the three-dimensional studies of protein structure. But synchrotron x-ray beams are now the mainstay of research extending from material science to structural biology to diagnostic imaging.

It is, definitely, new news that these high-quality, tunable x-ray beams are now available for the university, industrial or clinical laboratory. Unlike the stadium-sized synchrotron light sources, the Compact Light Source will fit into a typical university x-ray lab. The reduction in scale and cost is a factor of 200--made possible by using a laser beam instead of the "undulator" magnets of the large synchrotrons.

The Compact Light Source prototype effort was one of the advanced technology projects funded by the first phase of the NIGMS Protein Structure Initiative (PSI). Its rapid development was enabled by a blend of commercial technology and the creative inventions of the world-class Lyncean team. "We have an outstanding staff with decades of experience; the CLS electron storage ring was turned on last June and has been operating since then." Ruth said. "Our laser system was tested in parallel and then installed in late January, 2006. We installed our x-ray window on February 21, tuned up th

Contact: Ronald Ruth
Lyncean Technologies, Inc.

Page: 1 2

Related biology news :

1. Mini-synchrotron could increase access to key research tool
2. The worlds smallest synchrotron, MIRRORCLE-6X, now commercially available
3. Study produces conflicting findings on the use of anti-anemia drug in cancer patients
4. Smoking produces changes in human brain like those in animals using illicit drugs
5. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
6. Single genetic defect produces specific cognitive deficit in mice
7. FSU research produces images of AIDS virus that may shape vaccine
8. BiovaxID produces long term clinical remission and 95 percent overall survival
9. Hedgehog protein blocks fat production, produces more bone
10. Lateral thinking produces first map of gene transmission
11. Saudi Arabias KAUST names WHOI first research partner

Post Your Comments:

(Date:8/3/2020)... ... August 03, 2020 , ... ... new partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing ... their laboratory supply chain for more than 10 years. Early in the COVID-19 ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... therapeutics product portfolio with a near term focus on Type 2 diabetes and ... commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin ...
(Date:7/18/2020)... , ... July 16, 2020 , ... ... demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise control device to ... study reported that the Neoasis™ device attenuated the alarm sounds from patient monitors, ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... 06, 2020 , ... Bio-IT World has announced the winners ... the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance ... highlighting outstanding examples of how technology innovations and strategic initiatives can be powerful ...
(Date:6/28/2020)... , ... June 25, 2020 , ... The Indoor Lab, ... of Safe Space™ for businesses of all types to ensure cleanliness, distancing and occupancy ... , A Safe Space™ enabled business will provide a health performance index system ...
(Date:6/23/2020)... ... , ... Kerafast Inc. , developers of an online ... of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by ... entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. , ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, a biopharmaceutical ... has filed an Investigational New Drug application (IND) with the U.S. Food & ... drug candidate NBTX-001 in patients with panic disorder (PD). , "Adding a PD ...
Breaking Biology Technology:
Cached News: